We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Samsung to Invest in Hospital Patient Monitoring Firm

By HospiMedica International staff writers
Posted on 05 Feb 2015
Print article
Image: The EarlySense system sensor pad (Photo courtesy of EarlySense).
Image: The EarlySense system sensor pad (Photo courtesy of EarlySense).
As part of a strategic technology development plan in the Internet of Things (IoT), Samsung (Seoul, Republic of Korea) will invest USD 10 million in patient monitoring firm EarlySense (Ramat Gan, Israel).

The EarlySense system is designed for use in non-emergency room or even home settings, using sensors embedded into a mattress or chair cushion to monitor heartbeat, respiration rate, and movement. The data is transferred to a monitoring station, either local or remote, with the system setting off alarms in the event that something appears amiss. The system monitors patients who are unwilling or do not need to be connected physically to monitors and sensors in thousands of hospitals, nursing homes, and home settings around the world.

“EarlySense has developed and brought to market a unique, breakthrough technology that will improve the lives of consumers through health parameter sensing and monitoring,” said Gonzalo Martinez de Azagra, head of Samsung Ventures Israel. “Our investment is evidence of our belief in the need to bring sensors to hundreds of millions of consumers and we will do all that is in our hands to contribute to EarlySense’s accelerated growth.”

“IoT is a source of infinite potential that can enrich livelihoods and protect people depending on their needs and situations, further changing society and the economy,” said Yoon Boo-keun, head of Samsung Electronics’ consumer products unit. “Samsung’s IoT products will contribute to solving humanity’s issues by expanding the scope of connection from home and cities, and to the globe.”

“We are happy to have Samsung join our vision of bringing smart sensors to health and wellness at homes, hospitals and long term care,” said Avner Halperin, CEO of EarlySense.
”As a global leader in consumer products, Samsung can increase our reach to homes and will facilitate accelerated growth in that market. We are also honored by the vote of confidence from our existing investors, including Welch Allyn and the ongoing partnership we share together.”

The other half of EarlySense’s USD 20 million investment round was shared with Pitango Venture Capital (Herzliya, Israel), medical device manufacturer Welch Allyn (Skaneateles Falls, NY, USA), which has integrated it in the Connex clinical surveillance system (CSS), JK&B, Proseed, and Noaber.

Related Links:

Samsung 
EarlySense
Pitango Venture Capital


New
Gold Supplier
Conductive Gel
Tensive
New
Plug-In Patient Monitor
HT8
New
Patient Positioning Devices & OR Accessories
SchureMed Tools
New
High-Frequency X-Ray Generator
Battery X-Ray Generator

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Surgical Techniques

view channel
Image: The deployable electrodes are ideal for minimally invasive craniosurgery (Photo courtesy of EPFL)

Soft Robotic Electrode Offers Minimally Invasive Solution for Craniosurgery

Minimally invasive medical procedures offer numerous benefits to patients, including decreased tissue damage and shorter recovery periods. However, creating equipment that can pass through a small opening... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.